{
    "RADCURE-2712": {
        "question": "Age: 33.2, Sex: Female, ECOG PS: ECOG 0, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T2, N: N0, M : M0, Stage: II, Path: Squamous Cell Carcinoma, HPV: positive, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 0\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-positive cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The provided bounding box coordinates are [[271, 206, 79, 271, 232, 96], [271, 206, 79, 271, 232, 96]]. Both bounding boxes are identical, indicating a single region of interest (ROI) within the CT scan.\n\n2. The coordinates are normalized relative to the original image size, but without the original image dimensions, exact anatomical localization is limited. However, the z, y, x ranges suggest a small, localized volume.\n\n3. The CT image slice shows a sagittal view of the head and neck region. The masked ROI is highlighted in blue, located anteriorly near the oropharyngeal region.\n\n4. Visible anatomical structures in this region typically include the base of tongue, oropharynx, soft palate, and possibly the upper airway.\n\n5. The ROI appears to be a localized lesion or abnormality in the oropharyngeal area, possibly representing a tumor or involved lymph node.\n\n6. From a radiation oncology perspective, the size and location of this lesion are critical for planning targeted radiation therapy, especially if this is a squamous cell carcinoma related to HPV.\n\n7. The small size and localized nature of the lesion suggest a potentially favorable prognosis if treated appropriately with radiation therapy.\n\nFinal answer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: no\nReason: HPV+ oropharynx cases under RT are within scope\n---",
        "Round 2-role-comment": "radiation oncologist:alive",
        "Round 2-num_agents": 1,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}